Human Genome reports positive results on lupus drug
15th Nov 2006, 05:02 GMT
Human Genome Sciences has presented positive results of an extended phase II trial that demonstrated that lymphostat-B reduced disease activity in patients with lupus.
Human Genome reports positive results on lupus drug related news:
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
- Human Genome Says Lupus Drug Promising — Operations-Related News from StratCenter.com
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
- Positive Results for Anti-Cholesterol Drug — NYT > Business
- ZymoGenetics, Serono present positive results for atacicept — Pharmaceutical Business Review Latest News
- ZymoGenetics encouraged by early results on lupus treatment — bizjournals.com Health Care:Biotechnology headlines
- EntreMed Sees Positive Study Results — Operations-Related News from StratCenter.com
- ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus — PR Newswire: All Releases
- Arqule Early Cancer Study Shows Progress — Bio-Technology News from StratCenter.com
- HHS: No H5N1 strain found in U.S. so far — FCW.com RSS Feeds
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol